These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1489489)

  • 1. Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.
    Cabral AR; Cabiedes J; Alarcón-Segovia D; Sánchez-Guerrero J
    J Autoimmun; 1992 Dec; 5(6):787-801. PubMed ID: 1489489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of four subpopulations of IgG anticardiolipin antibodies in patients with primary antiphospholipid syndrome on the basis of their requirement for beta 2-glycoprotein-I and their unmasking by heat.
    Cabiedes J; Cabral AR; Alarcon-Segovia D
    Clin Exp Rheumatol; 1994; 12(2):123-7. PubMed ID: 8039278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
    Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
    J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
    Radway-Bright EL; Ravirajan CT; Isenberg DA
    Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
    Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
    Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
    Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
    Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
    J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.
    Cabral AR; Amigo MC; Cabiedes J; Alarcon-Segovia D
    Am J Med; 1996 Nov; 101(5):472-81. PubMed ID: 8948270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome.
    Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG
    Lupus; 1999; 8(3):234-9. PubMed ID: 10342717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
    Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid cofactor.
    Gharavi AE
    Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.
    Tebo AE
    Lupus; 2014 Oct; 23(12):1313-6. PubMed ID: 25228736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.